Propranolol improves impaired hepatic phosphatidylinositol 3-kinase/akt signaling after burn injury.

Keyphrases

• Adrenergic Receptor Antagonist 33%
• Attenuation 33%
• Burn Injury 100%
• C-Jun N-terminal Kinase 66%
• Catecholamine Release 33%
• Catecholamines 33%
• Endoplasmic Reticulum Stress (ER stress) 100%
• Endoplasmic Reticulum Stress Response 66%
• Insulin Receptor Signaling 66%
• Insulin Receptor Substrate 1 (IRS1) 33%
• Insulin Resistance 33%
• Insulin Sensitivity 33%
• Kinase Activation 33%
• Non-selective 33%
• Phosphatidylinositol 3-kinase/Akt Signaling 100%
• Phosphoinositide 3-kinase (PI3K) 33%
• Phosphorylation 33%
• Propranolol 100%
• Severe Burns 33%

Medicine and Dentistry

• Adrenergic Receptor Blocking Agent 20%
• Akt Signaling 100%
• Amino Terminal Sequence 40%
• Catecholamine 20%
• Catecholamine Release 20%
• Endoplasmic Reticulum Stress 100%
• Insulin Receptor 40%
• Insulin Receptor Substrate 1 20%
• Insulin Resistance 20%
• Insulin Sensitivity 20%
• Phosphoinositide 3-Kinase 100%
• Phosphotransferase 40%
• Propranolol 100%
• Thermal Burn 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Adrenergic Receptor Blocking Agent 25%
• Burn 100%
• Catecholamine 50%
• Insulin Receptor 50%
• Insulin Receptor Substrate 1 25%
• Insulin Resistance 25%
• Phosphatidylinositol 3 Kinase 100%
• Phosphotransferase 50%
• Propranolol 100%